Posted 6th March 2025
Posted 2 months ago
By GS Verde Group
SolasCure announces £10.9m Series B fundraise to advance wound care innovation
Biotechnology company, SolasCure, has announced the completion of its £10.9m Series B investment round, a deal advised on by the GS Verde Group.